Pitcairn’s State Street Technology Select Sector SPDR ETF XLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19,068
Closed -$2.69M 607
2025
Q3
$2.69M Hold
19,068
0.21% 79
2025
Q2
$2.41M Hold
19,068
0.16% 121
2025
Q1
$1.97M Hold
19,068
0.12% 156
2024
Q4
$2.22M Sell
19,068
-5,000
-21% -$582K 0.13% 139
2024
Q3
$2.72M Buy
24,068
+5,000
+26% +$549K 0.16% 120
2024
Q2
$2.16M Hold
19,068
0.13% 145
2024
Q1
$1.99M Hold
19,068
0.13% 150
2023
Q4
$1.84M Hold
19,068
0.14% 147
2023
Q3
$1.56M Hold
19,068
0.13% 150
2023
Q2
$1.66M Hold
19,068
0.14% 132
2023
Q1
$1.44M Sell
19,068
-22,200
-54% -$1.53M 0.13% 148
2022
Q4
$2.57M Buy
41,268
+22,200
+116% +$1.41M 0.26% 79
2022
Q3
$1.13M Hold
19,068
0.12% 158
2022
Q2
$1.21M Hold
19,068
0.13% 148
2022
Q1
$1.51M Hold
19,068
0.13% 146
2021
Q4
$1.66M Hold
19,068
0.11% 135
2021
Q3
$1.42M Hold
19,068
0.1% 149
2021
Q2
$1.41M Hold
19,068
0.09% 150
2021
Q1
$1.27M Buy
+19,068
New +$1.26M 0.09% 158

Other funds holding XLK

Pitcairn's XLK Position: Q4 2025 in Review

Pitcairn sold out of State Street Technology Select Sector SPDR ETF (XLK) in Q4 2025, closing a stake of 19,068 shares — an estimated $2.69M sold.

Pitcairn first reported a position in XLK in Q1 2021 and held it in 19 quarters. The position peaked at $2.72M in Q3 2024. 2,480 funds tracked by Wall St. Rank hold XLK as of Q4 2025.

  • Pitcairn reported no remaining State Street Technology Select Sector SPDR ETF position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 19,068 State Street Technology Select Sector SPDR ETF shares in Q4 2025, an estimated $2.69M.
  • Pitcairn first reported a position in State Street Technology Select Sector SPDR ETF in Q1 2021 and held it in 19 quarters.
  • Pitcairn's State Street Technology Select Sector SPDR ETF position peaked at $2.72M in Q3 2024.
  • 2,480 funds tracked by Wall St. Rank held State Street Technology Select Sector SPDR ETF as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.